Shellers Honored at Mural Arts Philadelphia’s 2021 Wall Ball
Stephen and Sandy Sheller were honorary attendees at Mural Arts Philadelphia’s 2021 Wall Ball, The Art of Wellbeing. Held virtually June 10, 2021 at 6:00 pm. The Sheller’s have been a long time supporter of Mural Arts’ Philadelphia’s First Same Day Pay Program, “Color Me Back.” The program has been successful addressing the growing problem […]
U.S. Supreme Court Declines J&J Appeal of $70M Risperdal Verdict
Johnson & Johnson is out of options after the U.S. Supreme Court declined to hear the pharmaceutical company’s appeal of a $70 million Risperdal verdict. In the cases of Yount vs. Janssen Pharmaceuticals, the 2019 Superior Court of Pennsylvania ruling stands. Yount’s doctor prescribed Risperdal off-label to address behavioral problems associated with autism when he […]
CEOs Receive Massive Bonuses Despite Ethics Scandals, Pass Cost on to Shareholders
When executive compensation is tied solely to short term profits, and not balanced against company payouts for wrongdoing, there’s an increased incentive for executive fraud. Recently Wells Fargo bank made headlines when bank employees opened million of fake accounts in customer’s names to meet quotas. Wells Fargo CEO testified before congress and passed the blame […]
SCOTUS Declines to Hear Argument Over FCA “Objective Falsehood”
The U.S. Supreme Court has decline to hear argument over “objective falsehood” under the False Claims Act (FCA). This has been a hot button issue in litigation that has federal courts split and left federal contractors, and the lawyers who represent them, with no clear answers. The question posed: What evidence is required to prove […]
Trump’s out of office. Allegations of his admission fraud still stand
Stephen Sheller, founder of Sheller P.C., and Eric Orts, Guardsmark Professor at the Wharton School at the University of Pennsylvania, penned a second request to the university’s administration for a formal investigation into allegations former President Trump committed admission fraud. Full letter below published as a guest column in The Daily Pennsylvanian. Stephen Sheller and Eric Orts’ previous letters […]
Stephen Sheller Honored as The Legal’s 2020 Pennsylvania Trailblazer
2020 Pennsylvania Trailblazers brought to you by The Legal Intelligencer Watch: Deadly Drugs – Johnson & Johnson’s Risperdal
Health and Life Science Litigation in 2021
With the Biden administration taking the White House last month, the new administration has been vocal about enforcing antitrust and fraud laws, especially as it pertains to those who took advance of federal pandemic relief funds. According to Bloomberg Law’s Expect Turbocharged Enforcement Under a Biden DOJ, the new administration’s DOJ will likely be “increasing corporate […]
DOJ Files Civil Suit Against Walmart, Walmart Retaliates
Last March federal prosecutors in Texas had a two-year investigation into Walmart’s questionable company policies for filling opioid prescriptions ended abruptly by Trump’s Department of Justice top officials just as prosecutors were ready to file criminal charges. Prosecutors felt Walmart’s history of non-compliance warranted criminal charges rather than another fine, which companies often write-off as […]
Purdue Pleads Guilty to Felonies, Plea Deal Receives Criticism
Purdue Pharma pleads guilty to criminal charges for illegal marketing of the its highly addictive painkiller, OxyContin. Corporations often pay penalties and fines for wrongdoing, yet criminal charges are rare. These charges include felony charges of defrauding federal health agencies and violating anti-kickback laws. The company also paid civil penalties for violating the False Claims […]
PA Supreme Court Upholds $70 Million Risperdal Verdict
The Pennsylvania Supreme Court has denied Johnson & Johnson’s request to overturn the $70 million Risperdal verdict upheld by a Superior court panel of judges last year. The case, A.Y. v. Janssen Pharmaceuticals, will now be remanded back to the PA Court of Common Pleas for a second trial to reconsider punitive damages. “We are […]
